文摘
Autologous fat grafting is considered a secondary reconstructive procedure and has the goal of improving quality of life. When lipofilling, autologous fat is transferred to the receiver location to optimize soft tissue contour of the recipient region. Breast cancer is the most common cancer in women. Thanks to individualized treatment methods, the cure rate continues to increase; however, increasingly more women must live many years with the consequences of surgery. Although the surgical procedures are becoming more individualized and are increasingly adapted to the individual situation, patients often have scars, defects, asymmetry, and volume loss of the breast, which are often enhanced by radiotherapy. Autologous fat is suitable for volume replacement of soft tissue and to improve the contour, skin perfusion, as well as augmentation of volume loss. Thereby, fat is suitable for breast reconstruction after mastectomy, flap surgery, or nipple/skin-sparing mastectomy followed by implant-based breast reconstruction. After breast-conserving therapy for breast cancer, asymmetry and scar tissue can also be treated with autologous fat. It should be noted that fat can only be transplanted into a healthy breast. Prior to autologous fat grafting, potential residual tumor or recurrence should be excluded. The longer the time interval between oncology surgery and fat grafting, the greater the safety. The success of this method is based on sound knowledge of the method, careful design of each treatment step, and depends on parameters, such as ability to analyze the breast by imaging, volume stability, and oncological safety.